David Grayzel
DirectoratJade Biosciences· In proxies 2023–2025
David Grayzel sits on 9 public boards.
Experience
- Jade BiosciencesPublic company · 3 yr
- Director2023 – Present · 3 yrStock in role -86%
- Affinia Therapeutics, Inc.Public company
- Director? – PresentNo stock prices for these years
- Comanche Biopharma Corp.Public company
- Director? – PresentNo stock prices for these years
- Q32 Bio, IncPublic company
- Director? – PresentNo stock prices for these years
- Radera Biotherapeutics, Inc.Public company
- Director? – PresentNo stock prices for these years
- Triana Biomedicines, Inc.Public company
- Director? – PresentNo stock prices for these years
- Vima Therapeutics, Inc.Public company
- Director? – PresentNo stock prices for these years
- Delinia, Inc.Public company · 11 yr
- Director2015 – Present · 11 yrNo stock prices for these years
- Surface Oncology, Inc.Public company · 12 yr
- Director2014 – Present · 12 yrNo stock prices for these years
- Cadent Therapeutics, Inc.Public company
- Director? – PresentNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?